COUGH is the #8 most commonly reported adverse reaction for TOBRAMYCIN SOLUTION, manufactured by Amneal Pharmaceuticals LLC. There are 417 FDA adverse event reports linking TOBRAMYCIN SOLUTION to COUGH. This represents approximately 2.1% of all 19,799 adverse event reports for this drug.
Patients taking TOBRAMYCIN SOLUTION who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH417 of 19,799 reports
COUGH is a less commonly reported adverse event for TOBRAMYCIN SOLUTION, but still significant enough to appear in the safety profile.
Other Side Effects of TOBRAMYCIN SOLUTION
In addition to cough, the following adverse reactions have been reported for TOBRAMYCIN SOLUTION:
COUGH has been reported as an adverse event in 417 FDA reports for TOBRAMYCIN SOLUTION. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with TOBRAMYCIN SOLUTION?
COUGH accounts for approximately 2.1% of all adverse event reports for TOBRAMYCIN SOLUTION, making it a notable side effect.
What should I do if I experience COUGH while taking TOBRAMYCIN SOLUTION?
If you experience cough while taking TOBRAMYCIN SOLUTION, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.